These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 17645584)

  • 1. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From fibrinogen to fibrin and its dissolution].
    Juhan-Vague I; Hans M
    Bull Acad Natl Med; 2003; 187(1):69-82; discussion 83-4. PubMed ID: 14556455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation and fibrinolysis in diabetes.
    Banga JD
    Semin Vasc Med; 2002 Feb; 2(1):75-86. PubMed ID: 16222598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
    Yudkin JS
    Diabetes Care; 1999 Apr; 22 Suppl 3():C25-30. PubMed ID: 10189559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus and prothrombotic activity].
    Malý J
    Vnitr Lek; 2010 Apr; 56(4):284-8. PubMed ID: 20465096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostasis and glycemic control in the cardiac surgical patient.
    Slaughter TF
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):176-9. PubMed ID: 16959746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adipose tissue in haemostasis, coagulation and fibrinolysis.
    Faber DR; de Groot PG; Visseren FL
    Obes Rev; 2009 Sep; 10(5):554-63. PubMed ID: 19460118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia and coagulation defects of insulin resistance.
    Frohlich J; Steiner G
    Int J Clin Pract Suppl; 2000 Oct; (113):14-22. PubMed ID: 11965826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
    Mafrici A; Proietti R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.
    Prior JO; Quiñones MJ; Hernandez-Pampaloni M; Facta AD; Schindler TH; Sayre JW; Hsueh WA; Schelbert HR
    Circulation; 2005 May; 111(18):2291-8. PubMed ID: 15851590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The insulin resistance syndrome and fibrinolysis disorders].
    Okapcová J; Hrnciar J
    Vnitr Lek; 1997 Jun; 43(6):373-8. PubMed ID: 9601868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
    Juhan-Vague I; Alessi MC; Morange PE
    Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, haemostasis and thrombosis.
    Alessi MC; Juhan-Vague I
    Thromb Haemost; 2008 Jun; 99(6):995-1000. PubMed ID: 18521499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.